Recurrent missense mutations in TMEM43 (ARVD5) due to founder effects cause arrhythmogenic cardiomyopathies in the UK and CanadaAnnika Haywood, Terry‐Lynn Young, Nancy D. Merner et al.|European Heart Journal|2012Cited by 57
Incidence and Outcomes of Out-of-Hospital Cardiac Arrest Patients Admitted to the Hospital in Canada from 2013 to 2017Nicholas Grubic, Aaron Sibley, Gerald Lebovic et al.|CJC Open|2024Cited by 6